US Stock MarketDetailed Quotes

CNS Pharmaceuticals (CNSP)

Watchlist
  • 2.311
  • +0.041+1.81%
Close May 1 16:00 ET
  • 2.311
  • 0.0000.00%
Post 20:01 ET
1.88MMarket Cap-0.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals (CNSP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
7.28%15.99M
87.06%5.99M
-42.20%3.25M
-4.70%2.41M
22.36%4.34M
-21.01%14.9M
-40.51%3.2M
24.15%5.63M
-37.20%2.53M
-28.05%3.54M
Selling and administrative expenses
10.74%6.21M
65.76%2.82M
-23.65%1.06M
-11.99%1.24M
-1.77%1.09M
17.66%5.61M
53.65%1.7M
23.20%1.38M
19.64%1.41M
-17.98%1.11M
-General and administrative expense
10.74%6.21M
65.76%2.82M
-23.65%1.06M
-11.99%1.24M
-1.77%1.09M
17.66%5.61M
53.65%1.7M
23.20%1.38M
19.64%1.41M
-17.98%1.11M
Research and development costs
5.19%9.77M
111.27%3.17M
-48.25%2.2M
4.52%1.17M
33.43%3.24M
-34.09%9.29M
-64.93%1.5M
24.47%4.24M
-60.76%1.12M
-31.88%2.43M
Operating profit
-7.28%-15.99M
-87.06%-5.99M
42.20%-3.25M
4.70%-2.41M
-22.36%-4.34M
21.01%-14.9M
40.51%-3.2M
-24.15%-5.63M
37.20%-2.53M
28.05%-3.54M
Net non-operating interest income expense
213.88%138.56K
38.86%32.88K
51.95%34.91K
1,414.90%34.42K
34,183.02%36.34K
217.98%44.14K
474.67%23.68K
107.99%22.97K
-163.05%-2.62K
101.95%106
Non-operating interest income
155.19%153.79K
34.58%35.61K
46.74%37.02K
1,992.63%38.61K
532.12%42.55K
117.65%60.26K
277.83%26.46K
95.84%25.23K
-76.35%1.85K
--6.73K
Non-operating interest expense
-5.52%15.23K
-1.91%2.72K
-6.29%2.12K
-6.23%4.19K
-6.29%6.21K
16.77%16.12K
-3.71%2.77K
22.85%2.26K
22.27%4.46K
21.87%6.63K
Other net income (expense)
-2.56K
Other non- operating income (expenses)
---2.56K
----
----
----
----
----
----
----
----
----
Income before tax
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Income tax
Net income
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Net income continuous Operations
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Minority interest income
Net income attributable to the parent company
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Basic earnings per share
92.34%-35.75
62.36%-10.15
96.24%-5.76
99.39%-6.42
99.81%-18.96
99.49%-466.89
99.90%-26.965
99.53%-153.2
96.39%-1.05K
85.02%-9.99K
Diluted earnings per share
92.34%-35.75
62.36%-10.15
96.24%-5.76
99.39%-6.42
99.81%-18.96
99.49%-466.89
99.90%-26.965
99.53%-153.2
96.39%-1.05K
85.02%-9.99K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 7.28%15.99M87.06%5.99M-42.20%3.25M-4.70%2.41M22.36%4.34M-21.01%14.9M-40.51%3.2M24.15%5.63M-37.20%2.53M-28.05%3.54M
Selling and administrative expenses 10.74%6.21M65.76%2.82M-23.65%1.06M-11.99%1.24M-1.77%1.09M17.66%5.61M53.65%1.7M23.20%1.38M19.64%1.41M-17.98%1.11M
-General and administrative expense 10.74%6.21M65.76%2.82M-23.65%1.06M-11.99%1.24M-1.77%1.09M17.66%5.61M53.65%1.7M23.20%1.38M19.64%1.41M-17.98%1.11M
Research and development costs 5.19%9.77M111.27%3.17M-48.25%2.2M4.52%1.17M33.43%3.24M-34.09%9.29M-64.93%1.5M24.47%4.24M-60.76%1.12M-31.88%2.43M
Operating profit -7.28%-15.99M-87.06%-5.99M42.20%-3.25M4.70%-2.41M-22.36%-4.34M21.01%-14.9M40.51%-3.2M-24.15%-5.63M37.20%-2.53M28.05%-3.54M
Net non-operating interest income expense 213.88%138.56K38.86%32.88K51.95%34.91K1,414.90%34.42K34,183.02%36.34K217.98%44.14K474.67%23.68K107.99%22.97K-163.05%-2.62K101.95%106
Non-operating interest income 155.19%153.79K34.58%35.61K46.74%37.02K1,992.63%38.61K532.12%42.55K117.65%60.26K277.83%26.46K95.84%25.23K-76.35%1.85K--6.73K
Non-operating interest expense -5.52%15.23K-1.91%2.72K-6.29%2.12K-6.23%4.19K-6.29%6.21K16.77%16.12K-3.71%2.77K22.85%2.26K22.27%4.46K21.87%6.63K
Other net income (expense) -2.56K
Other non- operating income (expenses) ---2.56K------------------------------------
Income before tax -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Income tax
Net income -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Net income continuous Operations -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Minority interest income
Net income attributable to the parent company -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Basic earnings per share 92.34%-35.7562.36%-10.1596.24%-5.7699.39%-6.4299.81%-18.9699.49%-466.8999.90%-26.96599.53%-153.296.39%-1.05K85.02%-9.99K
Diluted earnings per share 92.34%-35.7562.36%-10.1596.24%-5.7699.39%-6.4299.81%-18.9699.49%-466.8999.90%-26.96599.53%-153.296.39%-1.05K85.02%-9.99K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -